The Endocannabinoid System and its Relationship to Migraine: Tally Largent-Milnes, PhD
June 13th 2022The assistant professor of pharmacology at the University of Arizona College of Medicine Tucson shared her insight into the endocannabinoid system and its therapeutic potential in treating migraine. [WATCH TIME: 5 minutes]
Neuronal Complexity in a Model of Migraine: Amynah Pradhan, PhD
June 12th 2022The associate professor of psychiatry at the University of Illinois at Chicago shared the findings of her and colleagues’ work that suggest that distinct cytoarchitectural changes occur in the brain that may underlie migraine chronification. [WATCH TIME: 4 minutes]
Anxiety and Depression in Children and Adolescents With Migraine: Serena L. Orr, MD, MSc
June 12th 2022The pediatric neurologist and headache specialist at the University of Calgary discussed the work she presented at AHS 2022 on the incidence of anxiety and depressive disorders in the pediatric migraine population. [WATCH TIME: 6 minutes]
Assessing the Correlations With Sleep Issues and Risk of Dementia: Ruth Benca, MD, PhD
June 11th 2022The professor and chair of Psychiatry & Human Behavior at Wake Forest School of Medicine provided insight on the signs and risks associated with sleep disorders and Alzheimer disease. [WATCH TIME: 3 minutes]
Advantages With Extended Release Glatiramer Acetate in Relapsing, Progressive MS: Ehud Marom
June 10th 2022The president and chief executive officer of Mapi Pharma discussed the differences and additional benefits from glatiramer acetate depot, a new intramuscular extended-release version of the known multiple sclerosis medication. [WATCH TIME: 4 minutes]
The Need for Effective Treatments for Status Migrainosus: Matthew Robbins, MD
June 10th 2022The neurologist at Weill Cornell Medicine and NewYork-Presbyterian Hospital offered his insight into the hot topics at the American Headache Society Annual Scientific Meeting, including a presentation on the prevalence of status migrainosus. [WATCH TIME: 4 minutes]
Assessing Psychedelics for Therapeutic Potential in Cluster Headache: Bryan Roth, MD, PhD
June 9th 2022The Michael Hooker Distinguished Professor and director of the NIMH psychoactive drug screening program at University of North Carolina School of Medicine shared his insight into his keynote address at the American Headache Society Annual Scientific Meeting. [WATCH TIME: 8 minutes]
Expanding Knowledge About Advantages of Low-Sodium Oxybates: Richard Bogan, MD, FCCP, FAASM
June 9th 2022The associate clinical professor at the University of South Carolina School of Medicine discussed how JZP-258’s clinical profile has expanded since its original approval for narcolepsy, and whether it makes sense for all patients to consider. [WATCH TIME: 3 minutes]